P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection

Talia H. Swartz, Anthony M. Esposito, Natasha D. Durham, Boris M. Hartmann, Benjamin K. Chen

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences